GRACELL BIOTECHNOLOGIES-ADR (GRCL)

US38406L1035 - ADR

10.25  +0.01 (+0.05%)

After market: 10.25 0 (0%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

TTM
(2023-6-30)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
0.000.00370.00K0.000.00
Operating Expenses
626.84M624.66M463.94M214.40M146.58M
Research and Development
487.80M485.39M326.90M168.83M119.22M
Selling, General, and Administrative Expenses
139.05M139.27M137.04M45.57M27.36M
Operating Income
-626.84M-624.66M-463.57M-214.40M-146.58M
Interest Income/Expense
17.09M9.01M2.76M-2.20M6.49M
Other Income/Expense
8.53M8.16M9.06M4.70M1.43M
Income Before Taxes
-601.23M-607.49M-451.75M-211.90M-138.66M
Income Tax
N/A20.00KN/AN/AN/A
Net Income
-601.28M-607.51M-453.74M-274.63M-200.86M
EBITDA
N/A-565.89M-418.70M-192.81M-141.46M
 
Per Share Data
EPS Diluted Total Ops
-6.29-6.36-4.88-2.97-2.16
Non GAAP EPS
-1.30-1.30-1.05N/AN/A
 
Statistics
Profit Margin
N/AN/A-122632.43%N/AN/A
Operating Profit Margin
N/AN/A-125289.19%N/AN/A

All data in CNY

Charts